The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...
Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration ... 0.38% (RLD Lotemax SM) had an estimated ...
to market a generic equivalent of Lotemax SM ophthalmic gel of Bausch & Lomb Inc. Lupin is the exclusive first-to-file for this product and may be eligible to receive a 180-day exclusivity. This ...
Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...
Nearly one in three Europeans have sampled illegal drugs in their lifetime, but not every country is alike when it comes to their drug habits or their health impact. Regular drug use is associated ...